Illumina is a developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the analysis of genetic variation and biological function
Concurrent with the annual European Human Genetics Conference in Nice, France, Illumina reported that IntegraGen, a personalised healthcare company focused on the development and commercialisation of molecular diagnostic tests for complex diseases and provider of genetic services, has received Illumina Certified Service Provider (CSPro) certification for GoldenGate and Infinium genotyping technologies.
The GoldenGate assay is Illumina's first array-based platform that combines high-sample throughput, high multiplexing, and single-site CpG resolution for DNA methylation profiling.
The Infinium Whole-Genome Genotyping BeadArray solution offers single or multi-sample BeadChip formats and high-density architecture with the flexibility to add additional custom SNP Assays.
"IntegraGen is a company dedicated to offering high-quality services to other research institutes, either private or academic, and is the first laboratory in France to achieve CSPro certification for GoldenGate and Infinium Genotyping," said Karen Possemato, Illumina's director of corporate marketing.
"By becoming a member of CSPro, it has further demonstrated their commitment to the life science community, providing delivery of the highest-quality data available for genetic analysis applications".
